Therapies for Retinal Degeneration: Targeting Common Processes (Drug Discovery) 1st Edition

  • NH_07017
30 $
 

Therapies for Retinal Degeneration: Targeting Common Processes (Drug Discovery) 1st Edition

 
Sight loss and blindness affects many worldwide and the search for adequate drugs remains a challenge and an important area of interest in the drug discovery field. This book addresses approaches to the treatment of ocular diseases, a common component of which is neurodegeneration. The book discusses common cellular processes across disease pathways and common targets for drugs that target ocular disease as well as the newest approaches, such as cell and gene therapies.

Product details

  • Series: Drug Discovery (Book 66)
  • Hardcover: 260 pages
  • Publisher: Royal Society of Chemistry; 1 edition (September 25, 2018)
  • Language: English